Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2016, Article ID 5808215, 11 pages
http://dx.doi.org/10.1155/2016/5808215
Review Article

Therapeutic Strategies for Neuropathic Pain: Potential Application of Pharmacosynthetics and Optogenetics

1College of Pharmacy, Chosun University, Gwangju 501-759, Republic of Korea
2Department of Pharmacy, Hanyang University, ERICA Campus, 55 Hanyangdaehak-ro, Sannok-gu, Ansan, Gyeonggi-do 426-791, Republic of Korea

Received 26 August 2015; Revised 27 November 2015; Accepted 17 December 2015

Academic Editor: Seungkyu Lee

Copyright © 2016 Gum Hwa Lee and Sang Seong Kim. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. J. Bonica, “The need of a taxonomy,” Pain, vol. 6, no. 3, pp. 247–248, 1979. View at Publisher · View at Google Scholar · View at Scopus
  2. T. Koyama, J. G. McHaffie, P. J. Laurienti, and R. C. Coghill, “The subjective experience of pain: where expectations become reality,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 36, pp. 12950–12955, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. J. Sousa-Valente, A. P. Andreou, L. Urban, and I. Nagy, “Transient receptor potential ion channels in primary sensory neurons as targets for novel analgesics,” British Journal of Pharmacology, vol. 171, no. 10, pp. 2508–2527, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Kim, C. Kang, Y. S. Chan et al., “TRPV1 recapitulates native capsaicin receptor in sensory neurons in association with Fas-associated factor 1,” The Journal of Neuroscience, vol. 26, no. 9, pp. 2403–2412, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. C. Tsantoulas and S. B. McMahon, “Opening paths to novel analgesics: the role of potassium channels in chronic pain,” Trends in Neurosciences, vol. 37, no. 3, pp. 146–158, 2014. View at Publisher · View at Google Scholar · View at Scopus
  6. S. G. Waxman and G. W. Zamponi, “Regulating excitability of peripheral afferents: emerging ion channel targets,” Nature Neuroscience, vol. 17, no. 2, pp. 153–163, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. Y. Lee, C.-H. Lee, and U. Oh, “Painful channels in sensory neurons,” Molecules and Cells, vol. 20, no. 3, pp. 315–324, 2005. View at Google Scholar · View at Scopus
  8. F. March, N. G. Jones, and S. B. McMahon, “Future treatment strategies for neuropathic pain,” in Sensory Nerves, vol. 194 of Handbook of Experimental Pharmacology, pp. 589–615, Springer, Berlin, Germany, 2009. View at Publisher · View at Google Scholar
  9. M. A. Thacker, A. K. Clark, F. Marchand, and S. B. McMahon, “Pathophysiology of peripheral neuropathic pain: immune cells and molecules,” Anesthesia and Analgesia, vol. 105, no. 3, pp. 838–847, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. F. A. White, H. Jung, and R. J. Miller, “Chemokines and the pathophysiology of neuropathic pain,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 51, pp. 20151–20158, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. R.-R. Ji, Z.-Z. Xu, and Y.-J. Gao, “Emerging targets in neuroinflammation-driven chronic pain,” Nature Reviews Drug Discovery, vol. 13, no. 7, pp. 533–548, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. I. M. Chiu, L. B. Barrett, E. K. Williams et al., “Transcriptional profiling at whole population and single cell levels reveals somatosensory neuron molecular diversity,” eLife, vol. 3, Article ID e04660, 2014. View at Publisher · View at Google Scholar
  13. M. Crow, F. Denk, and S. B. McMahon, “Genes and epigenetic processes as prospective pain targets,” Genome Medicine, vol. 5, no. 2, p. 12, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. J. M. Dawes, A. Antunes-Martins, J. R. Perkins et al., “Genome-wide transcriptional profiling of skin and dorsal root ganglia after ultraviolet-B-induced inflammation,” PLoS ONE, vol. 9, no. 4, Article ID e93338, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Manteniotis, R. Lehmann, C. Flegel et al., “Comprehensive RNA-Seq expression analysis of sensory ganglia with a focus on ion channels and GPCRs in trigeminal ganglia,” PLoS ONE, vol. 8, no. 11, Article ID e79523, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. I. Méchaly, S. Bourane, D. Piquemal et al., “Gene profiling during development and after a peripheral nerve traumatism reveals genes specifically induced by injury in dorsal root ganglia,” Molecular and Cellular Neuroscience, vol. 32, no. 3, pp. 217–229, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. J. R. Perkins, A. Antunes-Martins, M. Calvo et al., “A comparison of RNA-seq and exon arrays for whole genome transcription profiling of the L5 spinal nerve transection model of neuropathic pain in the rat,” Molecular Pain, vol. 10, no. 1, article 7, 2014. View at Publisher · View at Google Scholar · View at Scopus
  18. D. Julius and A. I. Basbaum, “Molecular mechanisms of nociception,” Nature, vol. 413, no. 6852, pp. 203–210, 2001. View at Publisher · View at Google Scholar · View at Scopus
  19. R. Baron, “Neuropathic pain: a clinical perspective,” in Sensory Nerves, vol. 194 of Handbook of Experimental Pharmacology, pp. 3–30, Springer, Berlin, Germany, 2009. View at Google Scholar
  20. R. Baron, A. Binder, and G. Wasner, “Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment,” The Lancet Neurology, vol. 9, no. 8, pp. 807–819, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. C. J. Woolf and M. W. Salter, “Neuronal plasticity: increasing the gain in pain,” Science, vol. 288, no. 5472, pp. 1765–1768, 2000. View at Publisher · View at Google Scholar · View at Scopus
  22. R.-R. Ji and C. J. Woolf, “Neuronal plasticity and signal transduction in nociceptive neurons: implications for the initiation and maintenance of pathological pain,” Neurobiology of Disease, vol. 8, no. 1, pp. 1–10, 2001. View at Publisher · View at Google Scholar · View at Scopus
  23. H.-S. Xiao, Q.-H. Huang, F.-X. Zhang et al., “Identification of gene expression profile of dorsal root ganglion in the rat peripheral axotomy model of neuropathic pain,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 12, pp. 8360–8365, 2002. View at Publisher · View at Google Scholar · View at Scopus
  24. V. K. Gribkoff, “The therapeutic potential of neuronal KCNQ channel modulators,” Expert Opinion on Therapeutic Targets, vol. 7, no. 6, pp. 737–748, 2003. View at Publisher · View at Google Scholar · View at Scopus
  25. G. Munro and W. Dalby-Brown, “Kv7 (KCNQ) channel modulators and neuropathic pain,” Journal of Medicinal Chemistry, vol. 50, no. 11, pp. 2576–2582, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Calvo, J. M. Dawes, and D. L. Bennett, “The role of the immune system in the generation of neuropathic pain,” The Lancet Neurology, vol. 11, no. 7, pp. 629–642, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. C. Abbadie, J. A. Lindia, A. M. Cumiskey et al., “Impaired neuropathic pain responses in mice lacking the chemokine receptor CCR2,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 13, pp. 7947–7952, 2003. View at Publisher · View at Google Scholar · View at Scopus
  28. T. Lindenlaub and C. Sommer, “Cytokines in sural nerve biopsies from inflammatory and non-inflammatory neuropathies,” Acta Neuropathologica, vol. 105, no. 6, pp. 593–602, 2003. View at Google Scholar · View at Scopus
  29. N. Üçeyler, J. P. Rogausch, K. V. Toyka, and C. Sommer, “Differential expression of cytokines in painful and painless neuropathies,” Neurology, vol. 69, no. 1, pp. 42–49, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. R. Wagner and R. R. Myers, “Schwann cells produce tumor necrosis factor alpha: expression in injured and non-injured nerves,” Neuroscience, vol. 73, no. 3, pp. 625–629, 1996. View at Publisher · View at Google Scholar · View at Scopus
  31. C. Sommer, M. Schäfers, M. Marziniak, and K. V. Toyka, “Etanercept reduces hyperalgesia in experimental painful neuropathy,” Journal of the Peripheral Nervous System, vol. 6, no. 2, pp. 67–72, 2001. View at Publisher · View at Google Scholar · View at Scopus
  32. P. H. Schafer, A. K. Gandhi, M. A. Loveland et al., “Enhancement of cytokine production and AP-1 transcriptional activity in T cells by thalidomide-related immunomodulatory drugs,” The Journal of Pharmacology and Experimental Therapeutics, vol. 305, no. 3, pp. 1222–1232, 2003. View at Publisher · View at Google Scholar · View at Scopus
  33. F. A. White, J. Sun, S. M. Waters et al., “Excitatory monocyte chemoattractant protein-1 signaling is up-regulated in sensory neurons after chronic compression of the dorsal root ganglion,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 39, pp. 14092–14097, 2005. View at Publisher · View at Google Scholar · View at Scopus
  34. K. Ren and R. Torres, “Role of interleukin-1β during pain and inflammation,” Brain Research Reviews, vol. 60, no. 1, pp. 57–64, 2009. View at Publisher · View at Google Scholar · View at Scopus
  35. S. Ahmad and A. Dray, “Novel G protein-coupled receptors as pain targets,” Current Opinion in Investigational Drugs, vol. 5, no. 1, pp. 67–70, 2004. View at Google Scholar · View at Scopus
  36. A. Ohta and M. Sitkovsky, “Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage,” Nature, vol. 414, no. 6866, pp. 916–920, 2001. View at Publisher · View at Google Scholar · View at Scopus
  37. Z. Ali, M. Ringkamp, T. V. Hartke et al., “Uninjured C-fiber nociceptors develop spontaneous activity and alpha-adrenergic sensitivity following L6 spinal nerve ligation in monkey,” Journal of Neurophysiology, vol. 81, no. 2, pp. 455–466, 1999. View at Google Scholar · View at Scopus
  38. L. A. Birder and E. R. Perl, “Expression of alpha2-adrenergic receptors in rat primary afferent neurones after peripheral nerve injury or inflammation,” The Journal of Physiology, vol. 515, part 2, pp. 533–542, 1999. View at Google Scholar · View at Scopus
  39. A. Latremoliere and C. J. Woolf, “Central sensitization: a generator of pain hypersensitivity by central neural plasticity,” The Journal of Pain, vol. 10, no. 9, pp. 895–926, 2009. View at Publisher · View at Google Scholar · View at Scopus
  40. J. A. Lindia, M. G. Köhler, W. J. Martin, and C. Abbadie, “Relationship between sodium channel NaV1.3 expression and neuropathic pain behavior in rats,” Pain, vol. 117, no. 1-2, pp. 145–153, 2005. View at Publisher · View at Google Scholar · View at Scopus
  41. S. Leo, R. D'Hooge, and T. Meert, “Exploring the role of nociceptor-specific sodium channels in pain transmission using Nav1.8 and Nav1.9 knockout mice,” Behavioural Brain Research, vol. 208, no. 1, pp. 149–157, 2010. View at Publisher · View at Google Scholar · View at Scopus
  42. M. S. Farrell and B. L. Roth, “Pharmacosynthetics: reimagining the pharmacogenetic approach,” Brain Research, vol. 1511, pp. 6–20, 2013. View at Publisher · View at Google Scholar · View at Scopus
  43. B. R. Conklin, E. C. Hsiao, S. Claeysen et al., “Engineering GPCR signaling pathways with RASSLs,” Nature Methods, vol. 5, no. 8, pp. 673–678, 2008. View at Publisher · View at Google Scholar · View at Scopus
  44. M. S. Farrell, Y. Pei, Y. Wan et al., “A Gαs DREADD mouse for selective modulation of cAMP production in striatopallidal neurons,” Neuropsychopharmacology, vol. 38, no. 5, pp. 854–862, 2013. View at Publisher · View at Google Scholar
  45. E. Vardy, J. Robinson, C. Li et al., “A new DREADD facilitates the multiplexed chemogenetic interrogation of behavior,” Neuron, vol. 86, no. 4, pp. 936–946, 2015. View at Publisher · View at Google Scholar
  46. G. Aston-Jones and K. Deisseroth, “Recent advances in optogenetics and pharmacogenetics,” Brain Research, vol. 1511, pp. 1–5, 2013. View at Publisher · View at Google Scholar · View at Scopus
  47. G. D. Stuber and A. O. Mason, “Integrating optogenetic and pharmacological approaches to study neural circuit function: current applications and future directions,” Pharmacological Reviews, vol. 65, no. 1, pp. 156–170, 2013. View at Publisher · View at Google Scholar · View at Scopus
  48. I. Daou, A. H. Tuttle, G. Longo et al., “Remote optogenetic activation and sensitization of pain pathways in freely moving mice,” The Journal of Neuroscience, vol. 33, no. 47, pp. 18631–18640, 2013. View at Publisher · View at Google Scholar · View at Scopus
  49. S. M. Iyer, K. L. Montgomery, C. Towne et al., “Virally mediated optogenetic excitation and inhibition of pain in freely moving nontransgenic mice,” Nature Biotechnology, vol. 32, no. 3, pp. 274–278, 2014. View at Publisher · View at Google Scholar · View at Scopus
  50. C. Towne, M. Pertin, A. T. Beggah, P. Aebischer, and I. Decosterd, “Recombinant adeno-associated virus serotype 6 (rAAV2/6)-mediated gene transfer to nociceptive neurons through different routes of delivery,” Molecular Pain, vol. 5, article 52, 2009. View at Publisher · View at Google Scholar · View at Scopus
  51. M. J. Krashes, S. Koda, C. Ye et al., “Rapid, reversible activation of AgRP neurons drives feeding behavior in mice,” The Journal of Clinical Investigation, vol. 121, no. 4, pp. 1424–1428, 2011. View at Publisher · View at Google Scholar · View at Scopus
  52. P. J. Birch, L. V. Dekker, I. F. James, A. Southan, and D. Cronk, “Strategies to identify ion channel modulators: current and novel approaches to target neuropathic pain,” Drug Discovery Today, vol. 9, no. 9, pp. 410–418, 2004. View at Publisher · View at Google Scholar · View at Scopus
  53. V. S. Sohal, F. Zhang, O. Yizhar, and K. Deisseroth, “Parvalbumin neurons and gamma rhythms enhance cortical circuit performance,” Nature, vol. 459, no. 7247, pp. 698–702, 2009. View at Publisher · View at Google Scholar · View at Scopus
  54. Y. Lee, V. L. Dawson, and T. M. Dawson, “Animal models of Parkinson's disease: vertebrate genetics,” Cold Spring Harbor Perspectives in Medicine, vol. 2, no. 10, Article ID a009324, 2012. View at Publisher · View at Google Scholar · View at Scopus
  55. M. Giacca and S. Zacchigna, “Virus-mediated gene delivery for human gene therapy,” Journal of Controlled Release, vol. 161, no. 2, pp. 377–388, 2012. View at Publisher · View at Google Scholar · View at Scopus
  56. Y. Huang, X. Liu, L. Dong, Z. Liu, X. He, and W. Liu, “Development of viral vectors for gene therapy for chronic pain,” Pain Research and Treatment, vol. 2011, Article ID 968218, 8 pages, 2011. View at Publisher · View at Google Scholar · View at Scopus
  57. F. Mingozzi and K. A. High, “Therapeutic in vivo gene transfer for genetic disease using AAV: progress and challenges,” Nature Reviews Genetics, vol. 12, no. 5, pp. 341–355, 2011. View at Publisher · View at Google Scholar · View at Scopus
  58. A. Aiuti, F. Cattaneo, S. Galimberti et al., “Gene therapy for immunodeficiency due to adenosine deaminase deficiency,” The New England Journal of Medicine, vol. 360, no. 5, pp. 447–458, 2009. View at Publisher · View at Google Scholar · View at Scopus
  59. J. W. B. Bainbridge, A. J. Smith, S. S. Barker et al., “Effect of gene therapy on visual function in Leber's congenital amaurosis,” The New England Journal of Medicine, vol. 358, no. 21, pp. 2231–2239, 2008. View at Publisher · View at Google Scholar · View at Scopus
  60. M. A. Kay, “State-of-the-art gene-based therapies: the road ahead,” Nature Reviews Genetics, vol. 12, no. 5, pp. 316–328, 2011. View at Publisher · View at Google Scholar · View at Scopus
  61. D. J. Fink, J. Wechuck, M. Mata et al., “Gene therapy for pain: results of a phase I clinical trial,” Annals of Neurology, vol. 70, no. 2, pp. 207–212, 2011. View at Publisher · View at Google Scholar · View at Scopus
  62. A. A. Abdellatif, J. L. Pelt, R. L. Benton et al., “Gene delivery to the spinal cord: comparison between lentiviral, adenoviral, and retroviral vector delivery systems,” Journal of Neuroscience Research, vol. 84, no. 3, pp. 553–567, 2006. View at Publisher · View at Google Scholar · View at Scopus
  63. D. S. Latchman, “Herpes simplex virus vectors for gene therapy,” Molecular Biotechnology, vol. 2, no. 2, pp. 179–195, 1994. View at Publisher · View at Google Scholar · View at Scopus
  64. E. W. McCleskey and M. S. Gold, “Ion channels of nociception,” Annual Review of Physiology, vol. 61, pp. 835–856, 1999. View at Publisher · View at Google Scholar · View at Scopus
  65. H. Wang, H. Sun, K. Della Penna et al., “Chronic neuropathic pain is accompanied by global changes in gene expression and shares pathobiology with neurodegenerative diseases,” Neuroscience, vol. 114, no. 3, pp. 529–546, 2002. View at Publisher · View at Google Scholar · View at Scopus
  66. Z. Wang, M. Gerstein, and M. Snyder, “RNA-Seq: a revolutionary tool for transcriptomics,” Nature Reviews Genetics, vol. 10, no. 1, pp. 57–63, 2009. View at Publisher · View at Google Scholar · View at Scopus
  67. M. Heiman, A. Schaefer, S. Gong et al., “A translational profiling approach for the molecular characterization of CNS cell types,” Cell, vol. 135, no. 4, pp. 738–748, 2008. View at Publisher · View at Google Scholar · View at Scopus